We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Bcl-3 Shown to Block the Ubiquitination Pathway

By Biotechdaily staff writers
Posted on 22 Aug 2007
A recent report described how the regulatory protein Bcl-3 (B cell leukemia-3) regulated the inflammatory response by blocking the ubiquitination pathway.

In order to study Bcl-3's mode of action investigators at the University of Pennsylvania School of Medicine (Philadelphia, USA) genetically engineered a line of mice that lacked the gene for Bcl-3.

Results published in the August 3, 2007, edition of Science revealed that Bcl-3 interacted with p50, a protein that inhibits gene transcription by binding to DNA. More...
Normally p50 suppressed the DNA region coding for inflammation, halting the response to infection. However, p50 was unable to impede the inflammation response, as ubiquitination degraded it very fast. When the ubiquitination pathway in the Bcl-3–deficient mice was blocked, their cells were hypersensitive and unable to control responses to inflammatory substances.

"Our study identifies another layer of information that controls the inflammatory response,” said senior author Dr. Youhai Chen, associate professor of pathology and laboratory medicine at the University of Pennsylvania School of Medicine. "Bcl-3 appears to take in information from the body and, in response to infection, interferes with p50 degradation to decrease inflammatory response. Inflammation is natural. If we did not respond to infectious agents, bacteria would kill us. However, the inflammatory response must be controlled or we could also die. Bcl-3 helps regulate inflammation.”


Related Links:
Pennsylvania School of Medicine

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.